We have known about Truvada for a while. Now, an influential advisory panel of the Food and Drug Administration has endorsed the drug shown to prevent HIV infection in healthy people. It recommended approval of the pill for people at risk of contracting the virus. A final decision is expected next month, but if FDA does approve, it won’t be without a degree of controversy. We’re joined by Dr. Kenneth Mayer, medical research director at Fenway Health in Boston and a professor at Harvard Medical School.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. If you’ve been thinking about making a donation, this is the best time to do it. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. All donations between now and June 30 will be matched 2:1. Will you help keep our newsroom on strong footing by giving to The World?